Form 4: SLAB Executive Sells Shares After Option Exercise

Silicon Laboratories' Senior VP of Worldwide Sales & Marketing, Brandon Tolany, exercised stock options and subsequently sold a portion of the acquired common stock.

Summary

• Brandon Tolany, Senior VP of Worldwide Sales & Marketing at Silicon Laboratories Inc. (SLAB), reported transactions made pursuant to a Rule 10b5-1(c) plan.
• On December 4, 2025, Tolany exercised 4,246 non-qualified stock options at an exercise price of $43.82 per share.
• Immediately following the exercise on December 4, 2025, Tolany sold 4,246 shares of common stock at a weighted average price of $140.17 per share, with individual sale prices ranging from $140 to $140.62.
• On December 5, 2025, Tolany exercised an additional 1,954 non-qualified stock options at an exercise price of $43.82 per share.
• Immediately following the exercise on December 5, 2025, Tolany sold 1,954 shares of common stock at a weighted average price of $141.49 per share, with individual sale prices ranging from $140 to $142.59.
• Following these transactions, Tolany's direct beneficial ownership of Silicon Laboratories common stock stands at 62,381 shares.

Sentiment

Score: 4

Explanation: While the transactions were pre-planned under a Rule 10b5-1 plan, the sale of a significant number of shares by a Senior VP could be perceived as a slight negative by some investors, potentially indicating a belief that the stock's current valuation is fair or high.

Positives

• The executive exercised stock options, indicating that the options were in-the-money and had value.
• Transactions were made pursuant to a Rule 10b5-1 plan, which suggests pre-planned sales rather than opportunistic timing based on non-public information.

Negatives

• The executive sold a total of 6,200 shares of common stock, reducing their direct beneficial ownership.
• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the executive's direct stake in the company.

Risks

• Insider selling, particularly by a Senior VP, could be interpreted by some investors as a lack of confidence in the company's near-term prospects, potentially leading to negative market sentiment.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the insider selling as a signal, potentially influencing their investment decisions regarding the company's stock.

Key Dates

Keywords

SLAB, Silicon Laboratories, insider trading, Form 4, stock option, share sale, executive transaction, 10b5-1 plan